Arcturus Therapeutics Holdings Inc.
ARCT
$6.72
$0.172.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.73% | -6.49% | 16.39% | 36.44% | -172.30% |
| Total Depreciation and Amortization | -14.64% | -10.68% | -4.17% | 4.81% | 19.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.01% | -27.93% | -16.99% | -4.21% | 2,885.95% |
| Change in Net Operating Assets | -88.38% | 42.96% | -3.69% | -174.75% | -381.93% |
| Cash from Operations | -24.31% | 2.94% | 5.52% | -831.30% | -230.11% |
| Capital Expenditure | 64.51% | 79.12% | 91.05% | 77.76% | 77.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 64.51% | 79.12% | 91.05% | 77.76% | 77.66% |
| Total Debt Issued | -- | -- | -25.00% | -25.00% | -- |
| Total Debt Repaid | -- | 25.00% | 25.00% | -- | -- |
| Issuance of Common Stock | 146.99% | -72.42% | -83.33% | -37.33% | 65.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 146.99% | 113.67% | -83.33% | 237.15% | 122.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.17% | 24.23% | -0.75% | -569.13% | -21.94% |